GB201520862D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB201520862D0
GB201520862D0 GBGB1520862.2A GB201520862A GB201520862D0 GB 201520862 D0 GB201520862 D0 GB 201520862D0 GB 201520862 A GB201520862 A GB 201520862A GB 201520862 D0 GB201520862 D0 GB 201520862D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1520862.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Priority to GBGB1520862.2A priority Critical patent/GB201520862D0/en
Publication of GB201520862D0 publication Critical patent/GB201520862D0/en
Priority to PCT/EP2016/078564 priority patent/WO2017089404A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
GBGB1520862.2A 2015-11-25 2015-11-25 Pharmaceutical composition Ceased GB201520862D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1520862.2A GB201520862D0 (en) 2015-11-25 2015-11-25 Pharmaceutical composition
PCT/EP2016/078564 WO2017089404A1 (en) 2015-11-25 2016-11-23 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1520862.2A GB201520862D0 (en) 2015-11-25 2015-11-25 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB201520862D0 true GB201520862D0 (en) 2016-01-13

Family

ID=55177258

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1520862.2A Ceased GB201520862D0 (en) 2015-11-25 2015-11-25 Pharmaceutical composition

Country Status (2)

Country Link
GB (1) GB201520862D0 (en)
WO (1) WO2017089404A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020031148A1 (en) * 2018-08-10 2020-02-13 Tykhonivska Nataliya Pharmaceutical composition, medicinal product and method of treatment of bronchopulmonary obstructive diseases
WO2020084549A1 (en) * 2018-10-25 2020-04-30 Glenmark Specialty S.A. Nebulization composition comprising glycopyrrolate and formoterol
CA3186956A1 (en) * 2020-07-31 2022-02-03 Chemo Research , S.L. Combination therapy for inhalation administration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013203244B2 (en) * 2009-10-16 2016-11-03 Jagotec Ag Improved formulations
CN103501776A (en) * 2011-02-17 2014-01-08 西普拉有限公司 Composition of glycopyrrolate and a beta2-agonist
CA2898682A1 (en) * 2013-01-31 2014-08-07 Prosonix Limited Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy
MY176191A (en) * 2013-12-30 2020-07-24 Chiesi Farm Spa Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination

Also Published As

Publication number Publication date
WO2017089404A1 (en) 2017-06-01

Similar Documents

Publication Publication Date Title
IL265360A (en) Pharmaceutical composition
IL265260B (en) Pharmaceutical composition
GB201409471D0 (en) Pharmaceutical composition
IL262654A (en) Pharmaceutical composition
IL265349A (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
SI3278801T1 (en) Pharmaceutical composition containing mirabegron
GB201506526D0 (en) Medicinal composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201521462D0 (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (en) Pharmaceutical compositions
PL3454838T3 (en) Pharmaceutical composition
GB201615917D0 (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
PL3089740T3 (en) Pharmaceutical composition
IL265436B (en) Pharmaceutical composition
PL3424500T3 (en) Pharmaceutical composition comprising famitinib
GB2529605B (en) Pharmaceutical composition
IL265428A (en) Pharmaceutical composition
PT3476391T (en) Pharmaceutical composition
GB201620513D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)